Literature DB >> 813756

Comparative morphological studies on the carcinogenic effect of 7,12-dimethylbenz(A)anthracene (DMBA) in normal or intrasplenic ovarian tissue of C3H mice.

J Hilfrich.   

Abstract

A single intravenous injection of 100 mg/kg body weight (b.w.) of 7, 12 dimethylbenz(a)anthracene (DMBA) induces a high percentage of ovarian granulosa cell tumours in C3H mice. After implantation of ovarian tissue into the spleen of gonadectomized female C3H mice similar tumours were found, resulting from an over-stimulation by pituitary gonadotrophins. In the present study the tumour development in intrasplenic ovarian tissue was observed after an additional single intravenous application of 100 mg/kg b.w. DMBA. It was found that the induction of granulosa cell tumours did not seem to be affected by the carcinogen injection whether 12 weeks before or 12 weeks after ovarian tissue was implanted into the spleen. The morphology of these neoplasms corresponds to the DMBA induced granulosa cell tumours in orthotopic ovaries. A direct carcinogenic effect of DMBA on ovarian cells in mice could not be demonstrated but there are indications that the additional DMBA application accelerated the destruction of the oocytes, which might result in a more rapid intrasplenic tumour induction.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 813756      PMCID: PMC2024797          DOI: 10.1038/bjc.1975.265

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Development and growth of tumors in ovaries transplanted in the spleen.

Authors:  W U GARDNER
Journal:  Cancer Res       Date:  1955-02       Impact factor: 12.701

2.  Inhibition of tumor formation in ovarian splenic implants after gonadotrophic antiserum.

Authors:  C A ELY
Journal:  Cancer Res       Date:  1959-01       Impact factor: 12.701

3.  Tumorigenesis in intrasplenic ovaries in mice.

Authors:  M J GUTHRIE
Journal:  Cancer       Date:  1957 Jan-Feb       Impact factor: 6.860

4.  The effect of the intrasplenic ovarian graft on pituitary gonadotropins.

Authors:  W E ACHILLES; S H STURGIS
Journal:  Endocrinology       Date:  1951-12       Impact factor: 4.736

5.  Experimental induction of ovarian tumors in mice treated with single administration of 7,12-dimethylbenz[a]anthracene, and its histopathological observation.

Authors:  I Kuwahara
Journal:  Gan       Date:  1967-06

6.  The chemical induction of ovarian tumours in mice.

Authors:  J MARCHANT
Journal:  Br J Cancer       Date:  1957-09       Impact factor: 7.640

7.  The effect of hypophysectomy on the development of ovarian tumours in mice treated with dimethylbenzanthracene.

Authors:  J MARCHANT
Journal:  Br J Cancer       Date:  1961-12       Impact factor: 7.640

8.  The development of ovarian tumours in ovaries grafted from mice pretreated with dimethylbenzanthracene. Inhibition by the presence of normal ovarian tissue.

Authors:  J MARCHANT
Journal:  Br J Cancer       Date:  1960-09       Impact factor: 7.640

9.  The induction of ovarian tumours in mice with 9:10-dimethyl-1:2-benzanthracene.

Authors:  J S HOWELL; J MARCHANT; J W ORR
Journal:  Br J Cancer       Date:  1954-12       Impact factor: 7.640

10.  The actio of four carcinogenic hydrocarbons on the ovaries of IF mice and the histogenesis of induced tumours.

Authors:  J K MODY
Journal:  Br J Cancer       Date:  1960-06       Impact factor: 7.640

View more
  2 in total

1.  New construction of an animal model for the orthotopic transplantation of an ovarian tumor.

Authors:  Hui Zhang; Xinping Gao; Yongan Yang; Weiming Wang; Jin Liu; Yijuan Liang; Hongli Wu; Jinjin Qin; Kun Pan; Yifeng Wang; Junrong Shi; Youju Ma
Journal:  J Ovarian Res       Date:  2014-06-11       Impact factor: 4.234

2.  Enhanced efficacy and specificity of epithelial ovarian carcinogenesis by embedding a DMBA-coated cloth strip in the ovary of rat.

Authors:  Yiping Huang; Wei Jiang; Yisheng Wang; Yufang Zheng; Qing Cong; Congjian Xu
Journal:  J Ovarian Res       Date:  2012-09-03       Impact factor: 4.234

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.